HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Carl L. Backer Robert D. Stewart Constantine Mavroudis Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Backer, C. L. Articles by Mavroudis, C. Search for Related Content PubMed Articles by Backer, C. L. Articles by Mavroudis, C. Related Collections Congenital - cyanotic Mechanical Circulatory Assistance Related Article

J Thorac Cardiovasc Surg 2007;134:1421-1428
© 2007 The American Association for Thoracic Surgery

Surgery for Congenital Heart Disease

Aprotinin is safe in pediatric patients undergoing cardiac surgery

^a Division of Cardiovascular–Thoracic Surgery, Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Ill
^b Division of Kidney Diseases, Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Ill
^c Children’s Memorial Hospital, and the Department of Pediatrics and Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill. and Mary Ann and J. Milburn Smith Child Health Research Program, Children’s Memorial Research Center, Chicago, Ill.

Read at the Eighty-seventh Annual Meeting of The American Association for Thoracic Surgery, Washington, DC, May 5-9, 2007.

Received for publication May 16, 2007; revisions received July 19, 2007; accepted for publication August 7, 2007.

^_* Address for reprints: Carl L. Backer, MD, Division of Cardiovascular-Thoracic Surgery, Children’s Memorial Hospital, 2300 Children’s Plaza, mc 22, Chicago, IL 60614. (Email: cbacker{at}childrensmemorial.org).

Objective: Aprotinin, a serine protease inhibitor, decreases transfusion requirements and inflammatory response after cardiopulmonary bypass. This study was done to determine whether aprotinin is associated with adverse outcomes, particularly mortality and acute kidney failure, in pediatric patients (<18 years of age) undergoing cardiopulmonary bypass.

Methods: We compared a cohort of all pediatric cardiopulmonary bypass operations from 1994–1999, when aprotinin was not used (n = 1230), with a cohort from 2000–2006, when all patients received high-dose aprotinin (n = 1251). Primary end points were operative and late mortality, acute kidney failure, need for dialysis, and neurologic complications. Association of aprotinin with primary end points was assessed by means of univariate analysis, multivariate logistic regression, and Cox regression analysis, where appropriate.

Results: The aprotinin group was younger (mean age, 3.49 ± 1.84 vs 3.64 ± 4.75 years; P = .019) and had a higher Aristotle score (7.8 ± 2.3 vs 7.2 ± 2.6, P < .001). Univariate and multivariate analysis showed no significant difference between the no-aprotinin and aprotinin groups for operative mortality (55 [4.5%] vs 47 [3.8%], P = .508), acute kidney failure (68 [6.0%] vs 69 [5.7%], P = .77), need for temporary dialysis (6 [0.49%] vs 12 [0.96%], P = .17), or neurologic complications (14 [1.1%] vs 17 [1.4%], P = .62). By means of Cox regression analysis, aprotinin had no influence on late mortality (24 vs 10 deaths, P = .078).

Conclusion: In this retrospective cohort study of pediatric patients undergoing cardiopulmonary bypass, there was no association between the use of aprotinin and acute kidney failure, need for dialysis, neurologic complications, and operative or late mortality. We continue to use aprotinin for all pediatric patients undergoing cardiopulmonary bypass.

Related Article

Discussion
J. Thorac. Cardiovasc. Surg. 2007 134: 1426-1428. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

				C. Murugesan, S. K. Banakal, R. Garg, S. Keshavamurthy, and K. Muralidhar The Efficacy of Aprotinin in Arterial Switch Operations in Infants Anesth. Analg., September 1, 2008; 107(3): 783 - 787. [Abstract] [Full Text] [PDF]